RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Helius Medical Technologies Stock

Helius Medical Technologies Equity 2024

Helius Medical Technologies Equity

2.35 M USD

Ticker

HSDT

ISIN

US42328V6039

WKN

A2JB8E

In 2024, Helius Medical Technologies's equity was 2.35 M USD, a -71.17% increase from the 8.15 M USD equity in the previous year.

Helius Medical Technologies Aktienanalyse

What does Helius Medical Technologies do?

Helius Medical Technologies Inc is a Canadian company that specializes in the development and marketing of novel medical devices. The company was founded in 2014 and has since experienced remarkable success. The company's main product is the Portable Neuromodulation Stimulation (PoNS) treatment, which offers a non-invasive therapy for conditions such as stroke, traumatic brain injury, or multiple sclerosis. It is a portable device applied to the patient's tongue, emitting weak electrical impulses to promote neural stimulation. The accompanying software allows clinics and hospitals to offer personalized treatment to patients. Helius Medical Technologies Inc is divided into various divisions to better organize its operations: development, sales, and research and development. The different divisions are designed to operate the core business independently. The company operates in North America, with its headquarters in Newtown, Pennsylvania. However, it also operates in Canada and other regions, including Europe, Latin America, and Asia. Helius Medical Technologies Inc maintains close ties to the scientific community to ensure its products are up to date. The company has also partnered with the Walter Reed National Military Medical Center to explore the potential of its PoNS technology in treating post-traumatic stress disorder (PTSD) in US military personnel and veterans. The business model of Helius Medical Technologies Inc is based on innovative solutions that enable top-notch medical treatments. Through continuous research and development, the company remains at the forefront of the medical technology industry. Helius Medical Technologies Inc is focused on growth, reflected in its ongoing search for new markets and products. In recent years, the company has experienced significant growth, driven by the introduction of its PoNS treatment and various shareholder investments. The revenue of Helius Medical Technologies Inc has steadily increased since its founding, thanks to the support of its customers and investors. In summary, Helius Medical Technologies Inc is a leading company in the field of medical technology. Through innovative research and development, the company has achieved impressive success in a short period of time. The PoNS treatment is a groundbreaking technology that will gain global significance in the future. Helius Medical Technologies Inc remains focused on growth, with a strong vision that enables it to improve the quality of healthcare worldwide. Helius Medical Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Helius Medical Technologies's Equity

Helius Medical Technologies's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Helius Medical Technologies's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Helius Medical Technologies's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Helius Medical Technologies's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Helius Medical Technologies’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Helius Medical Technologies stock

What is the equity of Helius Medical Technologies this year?

Helius Medical Technologies has equity of 2.35 M USD this year.

What was the equity of Helius Medical Technologies compared to the previous year?

The equity of Helius Medical Technologies has increased/decreased by -71.17% decreased compared to the previous year.

What impact does a high equity have on investors of Helius Medical Technologies?

A high equity is advantageous for investors of Helius Medical Technologies as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Helius Medical Technologies?

A low equity can be a risk for investors of Helius Medical Technologies, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Helius Medical Technologies affect the company?

An increase in equity of Helius Medical Technologies can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Helius Medical Technologies affect the company?

A reduction in equity of Helius Medical Technologies can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Helius Medical Technologies?

Some factors that can affect the equity of Helius Medical Technologies include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Helius Medical Technologies so important for investors?

The equity of Helius Medical Technologies is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Helius Medical Technologies take to change the equity?

To change equity, Helius Medical Technologies can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Helius Medical Technologies pay?

Over the past 12 months, Helius Medical Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Helius Medical Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Helius Medical Technologies?

The current dividend yield of Helius Medical Technologies is .

When does Helius Medical Technologies pay dividends?

Helius Medical Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Helius Medical Technologies?

Helius Medical Technologies paid dividends every year for the past 0 years.

What is the dividend of Helius Medical Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Helius Medical Technologies located?

Helius Medical Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Helius Medical Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Helius Medical Technologies from 12/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/21/2024.

When did Helius Medical Technologies pay the last dividend?

The last dividend was paid out on 12/21/2024.

What was the dividend of Helius Medical Technologies in the year 2023?

In the year 2023, Helius Medical Technologies distributed 0 USD as dividends.

In which currency does Helius Medical Technologies pay out the dividend?

The dividends of Helius Medical Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Helius Medical Technologies

Our stock analysis for Helius Medical Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Helius Medical Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.